title: First-Line Anti-Tubercular Drug Resistance of Mycobacterium tuberculosis in IRAN: A Systematic Review.
abstract: BACKGROUND
  The spread of drug-resistant tuberculosis (TB) is one of the major public health problems through the world. Surveillance of anti-TB drug resistance is essential for monitoring of TB control strategies. The occurrence of drug resistance, particularly multi-drug resistance Mycobacterium tuberculosis (MDR), defined as resistance to at least rifampicin (RIF) and isoniazid (INH), has become a significant public health dilemma. The status of drug-resistance TB in Iran, one of the eastern Mediterranean countries locating between Azerbaijan and Armenia and high-TB burden countries (such as Afghanistan and Pakistan) has been reported inconsistently. Therefore, the aim of this study was to summarize reports of first-line anti-tubercular drug resistance in M. tuberculosis in Iran.
  
  
  METHODS
  We systematically reviewed published studies on drug-resistant M. tuberculosis in Iran. The search terms were "Mycobacterium tuberculosis susceptibility" or "Mycobacterium tuberculosis resistant" and Iran.
  
  
  RESULTS
  Fifty-two eligible articles, published during 1998-2014, were included in this review. Most of the studies were conducted in Tehran. The most common used laboratory method for detecting M. tuberculosis drug resistant was Agar proportion. The highest resistance to first-line drugs was seen in Tehran, the capital city of Iran. The average prevalence of isoniazid (INH), rifampin (RIF), streptomycin (SM), and ethambotol (EMB) resistance via Agar proportion method in Tehran was 26, 23, 22.5, and 16%, respectively. In general, resistance to INH was more common than RIF, SM, and EMB in Tehran Conclusions: In conclusion, this systematic review summarized the prevalence and distribution of first-line anti-tubercular drug resistance of M. tuberculosis in Iran. Our results suggested that effective strategies to minimize the acquired drug resistance, to control the transmission of resistance and improve the diagnosis measures for TB control in Iran.
authors: Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences Tehran, Iran.
authors: Babak
authors: B
authors: Pourakbari
authors: Pediatric Infectious Disease Research Center, Tehran University of Medical SciencesTehran, Iran; Department of Infectious Diseases, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical SciencesTehran, Iran.
authors: Setareh
authors: S
authors: Mamishi
authors: Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences Tehran, Iran.
authors: Mona
authors: M
authors: Mohammadzadeh
authors: Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences Tehran, Iran.
authors: Shima
authors: S
authors: Mahmoudi
keywords: Iran; multidrug resistance tuberculosis (MDR); tuberculosis (TB)